UPC Analytics
ENDE

Outcome base rates

What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.

Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.
0%patentees prevail on the merits

1 merits decision (small sample)

0 won · 1 lost · Insufficient prior-period data

Win rate by year
Patentee win rate by year of first decision.
  • 2024: 0% (0/1)
Win rate by division
Top divisions by merits-decision volume.
  • Paris CD
    0%
    (n=1)
When patentees lose, why?
Of 1 loss…
100%
Patent invalidated1 (100%)No infringement found0 (0%)
PI grant rate
PI grant rate (conservative)
Infringement rate
Revocation rate
100%
1 revoked / partially · 0 maintained / amended
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
0% 0 / 1
Outcomes by category (detailed)
Stacked breakdown using sharper outcome enums — revocation cases split into revoked_full / revoked_partial / maintained_as_*, etc.
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
  • Revocation1
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
  • Paris CD1 casesPI grant rate: Infringement rate: Revocation rate: 100%
Recent decisions
Most recent decisions in scope.
  • 2024-11-05ACT_571669/2023RevokedParis Central Division (Section 1) revoked European Patent EP 3 498 115 B1 (Juul Labs - vaping device cartridge) in full, with effect for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Latvia, Luxembourg, Netherlands, Portugal and Sweden. The Court found the patent invalid for added matter (Art. 138(1)(c) / Art. 123(2) EPC). All of Juul Labs' auxiliary requests to amend the patent were rejected. Juul Labs ordered to bear costs.